2030년까지 아시아 태평양 생물생산 시장 예측 - 지역 분석 - 제품별(생물의약품 및 바이오시밀러, 백신, 세포 및 유전자 치료법, 핵산 치료제 등), 용도별(류마티스 관절염, 혈액 질환, 암, 당뇨병, 심혈관 질환 및 기타) ), 장비(업스트림 장비, 다운스트림 장비, 생물반응기, 소모품 및 부속품), 최종 사용자(바이오의약품 회사, 계약 제조 조직 및 기타)
블록버스터 생물학적 제제의 특허 만료로 아시아 태평양 생물생산 시장 활성화
생물학적 제제는 이전에 치료할 수 없었던 질병에 대한 유망한 새로운 치료법을 대표하며 제약 시장에서 매우 중요해지고 있습니다. 오리지널 생물학적 제제에 대한 특허는 향후 몇 년 내에 만료될 것으로 예상됩니다.
베스트셀러 생물학적 제제의 예상 특허 및 독점권 만료일은 다음 표에 나와 있습니다.
생물학적 제제 만료일
생물학적 제제
만료일
Avastin
2022년 1월
Cyramza
2023년 5월
Adcetris
2023년 8월
Abthrax < br> 2024년 10월
Gazyva/Gazyvaro
2024년 11월
Darzalex
2026년 5월
Ocrevus
2027년 4월
Emgality
2028년 9월
Hemlibra
2월 2028년
Llumetri
2028년 3월
Imfinzi
2028년 9월
Mylotarg
2028년 4월
Imfinzi
2028년 9월
Mylotarg
2028년 4월
Sylvant
2034년 7월
오리지널 생물학적 제제의 특허 만료 및 기타 지적 재산권으로 인해 향후 새로운 바이오시밀러를 출시해야 할 필요성이 생길 것입니다. 결과적으로, 시장 참가자들 간의 경쟁은 향후 몇 년 동안 업계에서 급증할 것입니다. 따라서 블록버스터 생물의약품의 특허 만료는 예측 기간 동안 생물생산 시장에 수익성 있는 기회를 창출할 것으로 예상됩니다.
아시아 태평양 생물생산 시장 개요
아시아 태평양 생물생산 시장은 중국, 일본, 인도, 한국, 호주, 한국 및 기타 아시아 태평양 지역으로 분류됩니다. 아시아 태평양 시장의 성장은 우수한 치료 솔루션에 대한 필요성 증가, 연구 개발 활동에 대한 집중 증가, 유리한 규제 시나리오와 같은 요인으로 인해 더 빠른 속도로 성장할 것으로 예상됩니다. 또한, 연구 활동을 촉진하기 위한 투자 증가와 의료 인프라 개발이 2022~2030년 동안 아시아 태평양 생물생산 시장을 주도할 것으로 추정됩니다.
중국에서는 헬스케어에 대한 수요가 빠르게 증가하고 있습니다. 노인 인구 증가, 만성 질환 발병률 증가, 의료 부문의 정부 이니셔티브 증가와 같은 요인이 중국의 세포 치료 시장을 주도하고 있습니다. 기본 및 민간 의료보험 제도의 개선도 국내 의료 부문의 성장을 가속화했습니다. 소득 수준이 높아지면서 보다 정교한 의료 서비스에 대한 수요가 높아졌습니다. 노인인구의 증가는 국내 전문의료계의 증가로 이어졌다. 중국에서는 암 발병률이 증가함에 따라 세포치료제 채택이 증가할 가능성이 높습니다. 중국 국가중앙암등록부에 따르면 중국에서는 430만 건의 새로운 암 사례가 등록됐다.
2030년까지 아시아 태평양 생물생산 시장 수익 및 예측(미화 백만 달러)
아시아 태평양 생물생산 시장 세분화
아시아 태평양 생물생산 시장은 제품, 응용 프로그램, 장비, 최종 사용자로 분류됩니다. , 및 국가.
제품을 기준으로 아시아 태평양 생물생산 시장은 생물의약품 및 바이오시밀러, 백신, 세포 및 유전자 치료, 핵산 치료제 등으로 분류됩니다. 생물의약품 및 바이오시밀러 부문은 2022년 아시아 태평양 생물생산 시장에서 가장 큰 점유율을 차지했습니다.
적용 측면에서 아시아 태평양 생물생산 시장은 류마티스 관절염, 혈액 질환, 암, 당뇨병, 심혈관 질환 등으로 분류됩니다. 암 부문은 2022년 아시아태평양 생물생산 시장에서 가장 큰 점유율을 차지했습니다.
장비별로 아시아 태평양 생물생산 시장은 업스트림 장비, 다운스트림 장비, 생물반응기, 소모품 및 액세서리로 구분됩니다. 소모품 및 액세서리 부문은 2022년 아시아 태평양 생물생산 시장에서 가장 큰 점유율을 차지했습니다.
최종 사용자 측면에서 아시아 태평양 생물생산 시장은 생물의약품 회사, 계약 제조 조직 등으로 분류됩니다. 바이오제약 기업 부문은 2022년 가장 큰 아시아 태평양 바이오생산 시장 점유율을 차지했습니다.
국가별로 아시아 태평양 바이오생산 시장은 호주, 중국, 인도, 일본, 한국 및 기타 아시아 태평양 지역으로 분류됩니다. 중국은 2022년 아시아 태평양 생물생산 시장 점유율을 장악했습니다.
Lonza Group AG, bbi-biotech GmbH, Danaher Corp, Sartorius AG, FUJIFILM Irvine Scientific Inc, Thermo Fisher Scientific Inc, Merck KGaA, F. Hoffmann-La Roche Ltd, 및 Bio-Rad Laboratories Inc.는 아시아 태평양 생물생산 시장에서 활동하는 선도적인 회사 중 일부입니다.
Table of Content
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Bioproduction Market - Key Industry Dynamics
4.1 Market Drivers
4.1.1 Rising Adoption of Regenerative Medicines
4.1.2 Increasing Prevalence of Chronic Diseases
4.2 Market Restraints
4.2.1 High Cost of Cell Therapy and Biosimilar Manufacturing
4.3 Market Opportunities
4.3.1 Patent Expiry of Blockbuster Biologics
4.4 Future Trends
4.4.1 Shift Toward Automated Cell Therapy Manufacturing
4.5 Impact Analysis
5. Bioproduction Market - Asia Pacific Market Analysis
5.1 Asia Pacific Bioproduction Market Revenue (US$ Mn), 2020 - 2030
6. Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 - by Product
6.1 Overview
6.2 Asia Pacific Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
6.3 Biologics and Biosimilars
6.3.1 Overview
6.3.2 Biologics and Biosimilars: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Vaccines
6.4.1 Overview
6.4.2 Vaccines: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Cell and Gene Therapies
6.5.1 Overview
6.5.2 Cell and Gene Therapies: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Nucleic Acid Therapeutics
6.6.1 Overview
6.6.2 Nucleic Acid Therapeutics: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.7 Others
6.7.1 Overview
6.7.2 Others: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7. Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 - by Application
7.1 Overview
7.2 Asia Pacific Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Cancer
7.3.1 Overview
7.3.2 Cancer: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Cardiovascular Diseases
7.4.1 Overview
7.4.2 Cardiovascular Diseases: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Rheumatoid Arthritis
7.5.1 Overview
7.5.2 Rheumatoid Arthritis: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Hematological Disorders
7.6.1 Overview
7.6.2 Hematological Disorders: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Diabetes
7.7.1 Overview
7.7.2 Diabetes: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 - by Equipment
8.1 Overview
8.2 Asia Pacific Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
8.3 Consumables and Accessories
8.3.1 Overview
8.3.2 Consumables and Accessories: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Downstream Equipment
8.4.1 Overview
8.4.2 Downstream Equipment: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Bioreactors
8.5.1 Overview
8.5.2 Bioreactors: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.5.2.1 Asia Pacific: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
8.6 Upstream Equipment
8.6.1 Overview
8.6.2 Upstream Equipment: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 - by End User
9.1 Overview
9.2 Asia Pacific Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Biopharmaceutical Companies
9.3.1 Overview
9.3.2 Biopharmaceutical Companies: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Contract Manufacturing Organizations
9.4.1 Overview
9.4.2 Contract Manufacturing Organizations: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10. Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 - Country Analysis
10.1 Asia Pacific: Bioproduction Market
10.1.1 Asia Pacific: Bioproduction Market, by Country, 2022 & 2030 (%)
10.1.1.1 China: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.1 China: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.2 China: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.1.3 China: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.1.4 China: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.1.4.1 China: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.1.5 China: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.2 India: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 India: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 India: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.2.4 India: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.2.5 India: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.2.5.1 India: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.2.6 India: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.3 Japan: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 Japan: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 Japan: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.3.4 Japan: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.3.5 Japan: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.3.5.1 Japan: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.3.6 Japan: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.4 Australia: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Australia: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.3 Australia: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.4.4 Australia: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.4.5 Australia: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.4.5.1 Australia: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.4.6 Australia: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.5 South Korea: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 South Korea: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.3 South Korea: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.5.4 South Korea: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.5.5 South Korea: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.5.5.1 South Korea: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.5.6 South Korea: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.6 Rest of Asia Pacific: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Asia Pacific: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.3 Rest of Asia Pacific: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.6.4 Rest of Asia Pacific: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.6.5 Rest of Asia Pacific: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.6.5.1 Rest of Asia Pacific: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.6.6 Rest of Asia Pacific: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
11. Bioproduction Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Bioproduction Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 . Lonza Group AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 bbi-biotech GmbH
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Danaher Corp
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Sartorius AG
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 FUJIFILM Irvine Scientific Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Thermo Fisher Scientific Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Merck KGaA
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 F. Hoffmann-La Roche Ltd
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Bio-Rad Laboratories Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
?
List of Tables
Table 1. Asia Pacific Bioproduction Market Segmentation
Table 2. Asia Pacific Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 3. China Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 4. China Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 5. China Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 6. China Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 7. China Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 8. India Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 9. India Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 10. India Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 11. India Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 12. India Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 13. Japan Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 14. Japan Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 15. Japan Bioproduction Market, by Equipment- Revenue and Forecast to 2030 (US$ Million)
Table 16. Japan Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 17. Japan Bioproduction Market, by End User- Revenue and Forecast to 2030 (US$ Million)
Table 18. Australia Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 19. Australia Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 20. Australia Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 21. Australia Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 22. Australia Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 23. South Korea Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 24. South Korea Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 25. South Korea Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 26. South Korea Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 27. South Korea Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 28. Rest of Asia Pacific Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 29. Rest of Asia Pacific Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 30. Rest of Asia Pacific Bioproduction Market, by Equipment- Revenue and Forecast to 2030 (US$ Million)
Table 31. Rest of Asia Pacific Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 32. Rest of Asia Pacific Bioproduction Market, by Equipment- Revenue and Forecast to 2030 (US$ Million)
Table 33. Recent Inorganic Growth Strategies in the Bioproduction Market
Table 34. Recent Organic Growth Strategies in the Bioproduction Market
Table 35. Glossary of Terms, Bioproduction Market
?
List of Figures
Figure 1. Asia Pacific Bioproduction Market Segmentation, By Country
Figure 2. Asia Pacific Bioproduction Market: Key Industry Dynamics
Figure 3. Asia Pacific Bioproduction Market: Impact Analysis of Drivers and Restraints
Figure 4. Asia Pacific Bioproduction Market Revenue (US$ Mn), 2020 - 2030
Figure 5. Asia Pacific Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
Figure 6. Biologics and Biosimilars: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Vaccines: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Cell and Gene Therapies: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Nucleic Acid Therapeutics: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Others: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Asia Pacific Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
Figure 12. Cancer: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Cardiovascular Diseases: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Rheumatoid Arthritis: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Hematological Disorders: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Diabetes: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Asia Pacific Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
Figure 19. Consumables and Accessories: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Downstream Equipment: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Bioreactors: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Upstream Equipment: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Asia Pacific Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
Figure 24. Biopharmaceutical Companies: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Contract Manufacturing Organizations: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Others: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Asia Pacific: Bioproduction Market, by Key Country - Revenue (2022) (US$ Million)
Figure 28. Asia Pacific: Bioproduction Market, by Country, 2022 & 2030 (%)
Figure 29. China: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. India: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. Japan: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Australia: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 33. South Korea: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 34. Rest of Asia Pacific: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 35. Growth Strategies in the Bioproduction Market
1. Lonza Group AG
2. bbi-biotech GmbH
3. Danaher Corp
4. Sartorius AG
5. FUJIFILM Irvine Scientific Inc
6. Thermo Fisher Scientific Inc
7. Merck KGaA
8. F. Hoffmann-La Roche Ltd
9. Bio-Rad Laboratories Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific bioproduction market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific bioproduction market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific bioproduction market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.